These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9728218)

  • 1. Poor-risk germ cell tumors. Recent developments.
    Dodd PM; Motzer RJ; Bajorin DF
    Urol Clin North Am; 1998 Aug; 25(3):485-93. PubMed ID: 9728218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular cancer.
    Nichols CR
    Curr Probl Cancer; 1998; 22(4):187-274. PubMed ID: 9743088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetics of peripheral blood CD34-positive cells and the optimum timing for harvesting peripheral blood stem cells during BEP chemotherapy in patients with testicular germ cell tumor].
    Hioki T; Ogawa K; Yamada Y; Fumino M; Sugimura Y
    Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):14-20. PubMed ID: 10689878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
    Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O
    Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor.
    Cochran PK; Chauvenet AR; Hart PS; de Graaf SS; Cushing B; Kroovand L; Wofford MM
    Med Pediatr Oncol; 1999 Jun; 32(6):436-7. PubMed ID: 10358703
    [No Abstract]   [Full Text] [Related]  

  • 10. [Testicular germ cell tumors].
    Dourthe LM; Ouachet M; Fizazi K; Droz JP
    Bull Cancer; 1998 Sep; (1 Suppl):26-39. PubMed ID: 9817070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: the Memorial Sloan-Kettering experience (1988-1999).
    Morris MJ; Bosl GJ
    Int J Cancer; 1999 Dec; 83(6):834-8. PubMed ID: 10597205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
    J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis germ-cell tumors: An unresolved challenge.
    Toner GC; Frydenberg M
    Semin Urol Oncol; 2002 Nov; 20(4):251-61. PubMed ID: 12489058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for good-risk germ-cell tumors.
    Ryan CJ; Bajorin DF
    Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience.
    Saxman SB; Finch D; Gonin R; Einhorn LH
    J Clin Oncol; 1998 Feb; 16(2):702-6. PubMed ID: 9469360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer].
    Hasumi H; Kishida T; Teranishi J; Nakaigawa N; Fujinami K; Ikeda I; Uemura H; Yao M; Takeda M; Noguchi S; Kubota Y
    Hinyokika Kiyo; 2002 Aug; 48(8):469-73. PubMed ID: 12243071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Bajorin DF; Bosl GJ; Lyn P; Vlamis V
    J Clin Oncol; 1997 Jul; 15(7):2546-52. PubMed ID: 9215823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.